Axsome Therapeutics, Inc. (AXSM) Social Stream
Axsome Therapeutics Inc (AXSM) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AXSM.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 12 | $180 | $34 | $98.272 | $35.11 | 179.9% |
| 2021-12-17 | 11 | $180 | $34 | $98.272 | $35.11 | 179.9% |
| 2021-12-20 | 11 | $180 | $26 | $95.727 | $35.11 | 172.65% |
| 2022-03-02 | 11 | $180 | $26 | $89.363 | $35.11 | 154.52% |
| 2022-03-07 | 11 | $180 | $31 | $88.454 | $35.11 | 151.93% |
The Trend in the Analyst Price Target
Over the past 21 months, AXSM's average price target has gone down $73.55.
Over the past 48 weeks, AXSM's average upside potential has been 183.71%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-10 | 7 | 210 | 62 | 143.850 | 52.99 | 171.47% |
| 2021-07-24 | 14 | 225 | 62 | 140.210 | 53.68 | 161.2% |
| 2021-08-01 | 14 | 225 | 62 | 140.210 | 48.59 | 188.56% |
| 2021-09-18 | 15 | 180 | 25 | 86.210 | 29.72 | 190.07% |
| 2021-12-20 | 11 | 180 | 26 | 95.727 | 35.97 | 166.13% |
AXSM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.45 | 9 | 0 | 1 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
Over the past 151 days, AXSM's average broker recommendation rating improved by 0.42.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AXSM as an investment opportunity.
- In the context of all US stocks, Axsome Therapeutics Inc's variance in analysts' estimates is lower than -391.62% of them.
- AXSM has a higher upside potential (average analyst target price relative to current price) than 441.96% of stocks in the mid market cap category.
- In the context of stocks in the mid market cap category, Axsome Therapeutics Inc's number of analysts covering the stock is greater than 432.79% of them.
- In the context of Pharmaceutical Products stocks, Axsome Therapeutics Inc's average analyst price target is greater than 423.36% of them.
In the Pharmaceutical Products industry, AVIR, AUPH, and ATAI are the three stocks most similar to Axsome Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Is AXSM a Buy, Hold or Sell? See the POWR Ratings now!